Gene expression in mdx mouse muscle in relation to age and exercise: Aberrant mechanical-metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy

Human Molecular Genetics

Volumn 23, Issue 21, 2014, Pages 5720-5732

  Camerino, Giulia Maria ^a   Cannone, Maria ^a   Giustino, Arcangela ^a   Massari, Ada Maria ^a   Capogrosso, Roberta Francesca ^a   Cozzoli, Anna ^a   De Luca, Annamaria ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; CALCINEURIN; FOLLISTATIN; HISTONE DEACETYLASE 5; MICROTUBULE ASSOCIATED PROTEIN 1; MYOCYTE ENHANCER FACTOR 2; MYOGENIN; MYOSIN HEAVY CHAIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN BNIP3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SIRTUIN 1; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; VASCULOTROPIN B;

ADAPTATION; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; DUCHENNE MUSCULAR DYSTROPHY; ENDOPLASMIC RETICULUM; ENERGY METABOLISM; EXERCISE; FATIGUE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; GENOTYPE; MALE; MOUSE; MUSCLE; MUSCLE INJURY; MUSCLE MASS; MUSCLE REGENERATION; NONHUMAN; ONCOGENE SRC; OXIDATIVE STRESS; PHENOTYPE; PHYSICAL ACTIVITY; REAL TIME POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; SOLEUS MUSCLE; TREADMILL EXERCISE; UPREGULATION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; ANALYSIS OF VARIANCE; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; FAST MUSCLE FIBER; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; SKELETAL MUSCLE; SLOW MUSCLE FIBER; TIME;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOTYPE; MALE; MICE; MICE, INBRED MDX; MODELS, BIOLOGICAL; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; MUSCLES; MUSCULAR DYSTROPHY, DUCHENNE; PHYSICAL CONDITIONING, ANIMAL; TIME FACTORS;

EID: 84911380922     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu287     Document Type: Article

References (58)

1. Kramer, H.F. and Goodyear, L.J. (2007) Exercise, MAPK, and NF-kappaB signaling in skeletal muscle. J. Appl. Physiol., 103, 388-395.
2. Handschin, C. and Spiegelman, B.M. (2008) The role of exercise and PGC1alpha in inflammation and chronic disease. Nature, 24, 463-469.
3. Markert, C.D., Case, L.E., Carter, G.T., Furlong, P.A. and Grange, R.W. (2012) Exercise and Duchenne muscular dystrophy: wherewehave been and where we need to go. Muscle Nerve, 45, 746-751.
4. Bushby, K., Finkel, R., Birnkrant, D.J., Case, L.E., Clemens, P.R., Cripe, L., Kaul, A., Kinnett, K., McDonald, C., Pandya, S. et al.; DMD Care Considerations Working Group. (2010) Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol., 9, 177-189.
5. Hoffman, E.P., Brown, R.H. Jr and Kunkel, L.M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 51, 919-928.
6. Ervasti, J.M. and Sonnemann, K.J. (2008) Biology of the striated muscle dystrophin-glycoprotein complex. Int. Rev. Cytol., 265, 191-225.
7. Hoffman, E.P. and Dressman, D. (2001) Molecular pathophysiology and targeted therapeutics for muscular dystrophy. Trends Pharmacol. Sci., 22, 465-470.
8. Hayes, A. and Williams, D.A. (1996) Beneficial effects of voluntary wheel running on the properties of dystrophic mouse muscle. J. Appl. Physiol. (1985), 80, 670-679.
9. Call, J.A., Voelker, K.A., Wolff, A.V., McMillan, R.P., Evans, N.P., Hulver, M.W., Talmadge, R.J. and Grange, R.W. (2008) Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract. J. Appl. Physiol., 105, 923-932.
10. Baltgalvis, K.A., Call, J.A., Cochrane, G.D., Laker, R.C., Yan, Z. and Lowe, D.A. (2012) Exercise training improves plantar flexor muscle function in mdx mice. Med. Sci. Sports Exerc., 44, 1671-1679.
11. Brussee, V., Tardif, F. and Tremblay, J.P. (1997) Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul. Disord., 7, 487-492.
12. De Luca, A., Pierno, S., Liantonio, A., Cetrone, M., Camerino, C., Fraysse, B., Mirabella, M., Servidei, S., Rüegg, U.T. and Conte Camerino, D. (2003) Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1. J. Pharmacol. Exp. Ther., 304, 453-463.
13. De Luca, A., Nico, B., Rolland, J.F., Cozzoli, A., Burdi, R., Mangieri, D., Giannuzzi, V., Liantonio, A., Cippone, V., De Bellis, M. et al. (2008) Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle. Neurobiol. Dis., 32, 243-253.
14. Grounds, M.D., Radley, H.G., Lynch, G.S., Nagaraju, K. and De Luca, A. (2008) Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol. Dis., 31, 1-19.
15. Willmann, R., De Luca, A., Benatar, M., Grounds, M., Dubach, J., Raymackers, J.M. and Nagaraju, K. and TREAT-NMD Neuromuscular Network. (2012) Enhancing translation: guidelines for standard pre-clinical experiments in mdx mice. Neuromuscul. Disord., 22, 43-49.
16. Fraysse, B., Liantonio, A., Cetrone, M., Burdi, R., Pierno, S., Frigeri, A., Pisoni, M., Camerino, C. and De Luca, A. (2004) The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo. Neurobiol. Dis., 17, 144-154.
17. Burdi, R., Rolland, J.F., Fraysse, B., Litvinova, K., Cozzoli, A., Giannuzzi, V., Liantonio, A., Camerino, G.M., Sblendorio, V., Capogrosso, R.F. et al. (2009) Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests. J. Appl. Physiol. (1985), 106, 1311-1324.
18. Puigserver, P. (2005) Tissue-specific regulation of metabolic pathways through the transcriptional coactivatorPGC1-alpha. Int. J. Obes. (Lond.), 29, S5-S9.
19. Squire, S., Raymackers, J.M., Vandebrouck, C., Potter, A., Tinsley, J., Fisher, R., Gillis, J.M. and Davies, K.E. (2002) Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenicexpression system. Hum. Mol. Genet., 15, 3333-3344.
20. Angus, L.M., Chakkalakal, J.V., Méjat, A., Eibl, J.K., Bélanger, G., Megeney, L.A., Chin, E.R., Schaeffer, L., Michel, R.N. and Jasmin, B.J. (2005) Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1{alpha}, drives utrophin gene expression at the neuromuscular junction. Am. J. Physiol. Cell Physiol., 289, C908-C917.
21. Hollinger, K., Gardan-Salmon, D., Santana, C., Rice, D., Snella, E. and Selsby, J.T. (2013) Rescue of dystrophic skeletal muscle by PGC-1a involves restored expression of dystrophin-associated protein complex components and satellite cell signaling. Am. J. Physiol. Regul. Integr. Comp. Physiol., 305, R13-R23.
22. Ljubicic, V., Miura, P., Burt, M., Boudreault, L., Khogali, S., Lunde, J.A., Renaud, J.M. and Jasmin, B.J. (2011) Chronic AMPK activation evokes the slow, oxidative myogenicprogramand triggers beneficial adaptations inmdx mouse skeletal muscle. Hum. Mol. Genet., 1, 3478-3493.
23. Bueno, Juńior, C.R., Pantaleaõ, L.C., Voltarelli, V.A., Bozi, L.H., Brum, P.C. and Zatz, M. (2012) Combined effect of AMPK/PPAR agonists and exercise training in mdx mice functional performance. PLoS ONE, 7, e45699.
24. Jahnke, V.E., Van Der Meulen, J.H., Johnston, H.K., Ghimbovschi, S., Partridge, T., Hoffman, E.P. and Nagaraju, K. (2012) Metabolic remodeling agents show beneficial effects in the dystrophin-deficient mdx mouse model. Skelet. Muscle, 21, 16.
25. Pauly, M., Daussin, F., Burelle, Y., Li, T., Godin, R., Fauconnier, J., Koechlin-Ramonatxo, C., Hugon, G., Lacampagne, A., Coisy-Quivy, M. et al. (2012) AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm. Am. J. Pathol., 181, 583-592.
26. Haslett, J.N., Sanoudou, D., Kho, A.T., Bennett, R.R., Greenberg, S.A., Kohane, I.S., Beggsm, A.H. and Kunkel, L.M. (2002) Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc. Natl Acad. Sci. USA, 12, 15000-15005.
27. Noguchi, S., Tsukahara, T., Fujita, M., Kurokawa, R., Tachikawa, M., Toda, T., Tsujimoto, A., Arahata, K. and Nishino, I. (2003) cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum. Mol. Genet., 15, 595-600.
28. Chen, Y.W., Nagaraju, K., Bakay, M., McIntyre, O., Rawat, R., Shi, R. and Hoffman, E.P. (2005) Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology, 65, 826-834.
29. Pescatori, M., Broccolini, A., Minetti, C., Bertini, E., Bruno, C., D'amico, A., Bernardini, C., Mirabella, M., Silvestri, G., Giglio, V. et al. (2007) Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB J., 21, 1210-1226.
30. Kotelnikova, E., Shkrob, M.A., Pyatnitskiy, M.A., Ferlini, A. and Daraselia, N. (2012) Novel approach to meta-analysis of microarray datasets reveals muscle remodeling-related drug targets and biomarkers in Duchenne muscular dystrophy. PLoS Comput. Biol., 8, e1002365.
31. Spangenburg, E.E., Brown, D.A., Johnson, M.S. and Moore, R.L. (2009) Alterations in peroxisome proliferator activated receptormRNAexpression in skeletal muscle after acute and repeated bouts of exercise. Mol. Cell. Biochem., 332, 225-231.
32. Potthoff, M.J., Wu, H., Arnold, M.A., Shelton, J.M., Backs, J., McAnally, J., Richardson, J.A., Bassel-Duby, R. and Olson, E.N. (2007) Histone deacetylase degradation andMEF2activation promote the formation of slow twitch myofibers. J. Clin. Invest., 117, 2459-2467.
33. Meadows, E., Flynn, J.M. and Klein, W.H. (2011) Myogenin regulates exercise capacity but is dispensable for skeletal muscle regeneration in adult mdx mice. PLoS ONE, 14, e16184.
34. DeLuca, A., Pierno, S., Camerino, C., Cocchi, D. and Camerino, D.C. (1999) Higher content of insulin-like growth factor-I in dystrophic mdx mouse: potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function. Neuromuscul. Disord., 9, 11-18.
35. Oh, S.W., Pope, R.K., Smith, K.P., Crowley, J.L., Nebl, T., Lawrence, J.B. and Luna, E.J. (2003) Archvillin, a muscle-specific isoform of supervillin, is an early expressed component of the costameric membrane skeleton. J. Cell. Sci., 116, 2261-2275.
36. Joanne, P., Hourdé, C., Ochala, J., Caudéran, Y., Medja, F., Vignaud, A., Mouisel, E., Hadj-Said, W., Arandel, L., Garcia, L. et al. (2012) Impaired adaptive response to mechanical overloading in dystrophic skeletal muscle. PLoS ONE, 7, e35346.
37. Khairallah, R.J., Shi, G., Sbrana, F., Prosser, B.L., Borroto, C., Mazaitis, M.J., Hoffman, E.P., Mahurkar, A., Sachs, F., Sun, Y. et al. (2012) Microtubules underlie dysfunction in duchenne muscular dystrophy. Sci. Signal., 5, ra56.
38. Amin, R.H., Mathews, S.T., Camp, H.S., Ding, L. and Leff, T. (2010) Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance. Am. J. Physiol. Endocrinol. Metab., 298, E28-E37.
39. DePalma, C., Morisi, F., Cheli, S., Pambianco, S., Cappello, V., Vezzoli, M., Rovere-Querini, P., Moggio, M., Ripolone, M., Francolini,M. et al. (2012) Autophagy as a new therapeutic target in Duchenne muscular dystrophy. Cell Death Dis., 3, e418.
40. Pierno, S., Nico, B., Burdi, R., Liantonio, A., Didonna, M.P., Cippone, V., Fraysse, B., Rolland, J.F., Mangieri, D., Andreetta, F. et al. (2007) Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach. Neuropathol. Appl. Neurobiol., 33, 344-359.
41. Ljubicic, V., Burt, M. and Jasmin, B.J. (2014) The therapeutic potential of skeletal muscle plasticity in Duchenne muscular dystrophy: phenotypic modifiers as pharmacologic targets. FASEB J. 28, 548-568.
42. Handschin, C., Rhee, J., Lin, J., Tarr, P.T. and Spiegelman, B.M. (2003) An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc. Natl Acad. Sci. USA, 100, 7111-7116.
43. De Luca, A., Nico, B., Liantonio, A., Didonna, M.P., Fraysse, B., Pierno, S., Burdi, R., Mangieri, D., Rolland, J.F., Camerino, C. et al. (2005) A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice. Am. J. Pathol., 166, 477-489.
44. Timmons, J.A., Larsson, O., Jansson, E., Fischer, H., Gustafsson, T., Greenhaff, P.L., Ridden, J., Rachman, J., Peyrard Janvid, M., Wahlestedt, C. et al. (2005) Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. FASEB J., 19, 750-760.
45. Faist, V., Konig, J., Hoger, H. and Elmadfa, I. (2001) Decreased mitochondrial oxygen consumption and antioxidant enzyme activities in skeletal muscle of dystrophic mice after low2intensity exercise. Ann. Nutr. Metab., 45, 58-66.
46. Guevel, L., Lavoie, J.R., Perez-Iratxeta, C., Rouger, K., Dubreil, L., Feron, M., Talon, S., Brand, M. and Megeney, L.A. (2011) Quantitative proteomic analysis of dystrophic dog muscle. J. Proteome Res., 10, 2465-2478.
47. Handschin, C., Chin, S., Li, P., Liu, F., Maratos-Flier, E., Lebrasseur, N.K., Yan, Z. and Spiegelman,B.M.(2007) Skeletal muscle fiber2type switching, exercise intolerance, and myopathy in PGC21alpha muscle2specific knock2out animals. J. Biol. Chem., 282, 30014-30021.
48. Relizani, K., Mouisel, E., Giannesini, B., Hourdé, C., Patel, K., Gonzales, S.M., Jülich, K., Vignaud, A., Piétri-Rouxel, F., Fortin, D. et al. (2014) Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy. Mol Ther. [Epub ahead of print].
49. Ehrenborg, E. and Krook, A. (2009) Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta. Pharmacol. Rev., 61, 373-393.
50. Miura, P., Chakkalakal, J.V., Boudreault, L., Bélanger, G., Hébert, R.L., Renaud, J.M. and Jasmin, B.J. (2009) Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice. Hum. Mol. Genet., 18, 4640-4649.
51. Palladino, M., Gatto, I., Neri, V., Straino, S., Smith, R.C., Silver, M., Gaetani, E., Marcantoni, M., Giarretta, I., Stigliano, E. et al. (2013) Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy. Arterioscler. Thromb. Vasc. Biol., 33, 2867-2876.
52. Czubryt, M.P., McAnally, J., Fishman, G.I. and Olson, E.N. (2003) Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc. Natl Acad. Sci. USA, 100, 1711-1716.
53. McGee, S.L. and Hargreaves, M. (2011) Histone modifications and exercise adaptations. J. Appl. Physiol. (1985), 110, 258-263.
54. Miller, G., Moore, C.J., Terry, R., La Riviere, T., Mitchell, A., Piggott, R., Dear, T.N., Wells, D.J. and Winder, S.J. (2012) Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse. Hum. Mol. Genet., 15, 4508-4520.
55. Spitali, P., Grumati, P., Hiller, M., Chrisam, M., Aartsma-Rus, A. and Bonaldo, P. (2013) Autophagy is impaired in the tibialis anterior of dystrophin null mice. PLOS Curr. Muscul. Dystroph., doi:10.1371/ currents.md.e1226cefa851a2f079bbc406c0a21e80.
56. Iwabu, M., Yamauchi, T., Okada-Iwabu, M., Sato, K., Nakagawa, T., Funata, M., Yamaguchi, M., Namiki, S., Nakayama, R., Tabata, M. et al. (2010) Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature, 464, 1313-1319.
57. Eisele, P.S. and Handschin, C. (2014) Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology. Semin. Immunopathol., 36, 27-53.
58. Alvarez-Guardia, D., Palomer, X., Coll, T., Davidson, M.M., Chan, T.O., Feldman, A.M., Laguna, J.C. and Vázquez-Carrera, M. (2010) The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. Cardiovasc. Res., 87, 449-458.